Kiora Pharmaceuticals, Inc.
KPRX
$2.10
$0.2111.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.54M | -11.98M | -12.05M | 3.59M | 5.55M |
| Total Depreciation and Amortization | 106.70K | 82.70K | 69.10K | 65.70K | -31.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -784.80K | 1.66M | 1.47M | 1.23M | 1.76M |
| Change in Net Operating Assets | -812.90K | 2.40M | 2.74M | 3.67M | 955.90K |
| Cash from Operations | -10.03M | -7.84M | -7.77M | 8.56M | 8.23M |
| Capital Expenditure | 12.40K | 12.80K | -6.30K | -6.30K | -51.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.55M | 1.89M | -19.98M | -22.66M | -23.09M |
| Cash from Investing | 9.56M | 1.90M | -19.99M | -22.66M | -23.15M |
| Total Debt Issued | 2.75M | 1.00M | -- | -- | -- |
| Total Debt Repaid | -2.75M | -1.00M | -- | -- | -- |
| Issuance of Common Stock | 265.40K | 265.40K | 249.40K | 16.69M | 16.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 1.10K | -1.19M | -1.69M |
| Cash from Financing | 265.40K | 265.40K | 250.50K | 15.50M | 15.01M |
| Foreign Exchange rate Adjustments | 79.40K | 128.50K | 3.90K | -57.20K | 140.50K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -128.20K | -5.55M | -27.51M | 1.34M | 237.10K |